| Period Ending | Dec 30, 2009 |
|---|
|
Total Revenue
|
30,456
| | Cost of Revenue | 5,040 | | |
Gross Profit
|
25,414
| |
|
Operating Expenses |
|
Research Development |
-
|
|
Selling General and Administrative | 17,912 |
|
Non Recurring |
-
|
|
Others |
-
|
|
|
|
Total Operating Expenses |
-
| | | |
Operating Income or Loss
|
7,503
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 95 |
|
Earnings Before Interest And Taxes | 7,598 |
|
Interest Expense |
-
|
|
Income Before Tax | 7,598 |
|
Income Tax Expense | 799 |
|
Minority Interest | 36 |
|
|
|
Net Income From Continuing Ops | 6,840 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
|
Extraordinary Items |
-
|
|
Effect Of Accounting Changes |
-
|
|
Other Items |
-
| | | |
Net Income
|
6,840
| | Preferred Stock And Other Adjustments | (4,004) | | |
Net Income Applicable To Common Shares
|
2,835
|
|
0.08(3.15%) May 17, 3:36PM EDT